In which lipodystrophy is a buffalo hump seen?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Buffalo Hump in Lipodystrophy Syndromes

Buffalo hump, characterized by fat accumulation in the dorsocervical region, is most prominently seen in HIV-associated lipodystrophy and Cushing syndrome. In the context of lipodystrophy specifically, buffalo hump is a characteristic feature of HIV-associated lipodystrophy, which is an acquired form of lipodystrophy that occurs as a complication of antiretroviral treatment. 1

HIV-Associated Lipodystrophy

HIV-associated lipodystrophy presents with distinctive fat redistribution patterns:

  • The condition manifests as fat redistribution with loss of subcutaneous fat, increase in intra-abdominal fat, buffalo hump, or breast hypertrophy 1
  • It appears in three prevalent forms:
    • Generalized or localized lipoatrophy (involving extremities, buttocks, and face)
    • Lipohypertrophy with generalized or local fat deposition (involving abdomen, breasts, dorsocervical region [buffalo hump], and supraclavicular area)
    • Mixed pattern with central adiposity and peripheral lipoatrophy 1

Risk Factors and Associations

  • Increased duration of HIV infection 1
  • High viral load 1
  • Low CD4 counts before highly active antiretroviral therapy (HAART) 1
  • Antiretroviral treatment, particularly protease inhibitors, though it can occur with other regimens as well 1, 2
  • Hyperinsulinemia (higher fasting insulin levels are independently associated with buffalo hump) 3
  • Higher body mass index and waist/hip ratio 3

Metabolic Implications

  • Buffalo hump in HIV-associated lipodystrophy is not associated with hypercortisolism (unlike in Cushing syndrome) 2
  • It is associated with hyperinsulinemia but not necessarily with dyslipidemia 3
  • HAART-associated lipodystrophy normalizes resting energy expenditure but has only minor effects on lipolysis 1
  • The metabolic changes appear to be permanent, as discontinuation of HAART does not influence the degree of lipodystrophy 1

Other Lipodystrophy Syndromes with Buffalo Hump

Symmetrical Multiple Lipomatosis (Madelung's Disease)

  • Occurs preferentially in men who abuse alcohol 4
  • Classic subtype affects the upper body and nuchal region with a buffalo hump appearance 4
  • Often accompanied by metabolic components including obesity 4

Genetic Lipodystrophy Syndromes

  • Familial partial lipodystrophy (particularly Dunnigan variety) may present with fat redistribution, though buffalo hump is not as characteristic as in acquired forms 1
  • These disorders involve fat loss from extremities more than trunk 1

Clinical Management

  • Medical treatment of lipodystrophy itself is generally not effective 1
  • Avoiding antiretroviral drugs with strong metabolic adverse effects may prevent or partially reverse lipodystrophy 1
  • Management should focus on:
    • Screening for metabolic complications (insulin resistance, diabetes mellitus) 1, 3
    • Monitoring blood pressure, which is often elevated in patients with buffalo hump 3
    • Assessing for other features of lipodystrophy, as buffalo hump rarely occurs in isolation 3

Diagnostic Approach

When evaluating a patient with buffalo hump, consider:

  • HIV status and antiretroviral medication history 1
  • Screening for Cushing syndrome (24-hour urinary free cortisol, overnight dexamethasone suppression test) to rule out hypercortisolism 2
  • Assessment of insulin levels and glucose tolerance 3
  • Evaluation of body composition (dual-energy X-ray absorptiometry) to assess fat distribution patterns 2
  • Look for signs of lipodystrophy (loss of subcutaneous fat, triceps skinfold thickness, waist/hip ratio) 1

Buffalo hump in the context of HIV infection should prompt consideration of lipodystrophy syndrome and its metabolic implications, particularly insulin resistance and cardiovascular risk factors.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

"Buffalo hump" in men with HIV-1 infection.

Lancet (London, England), 1998

Research

Multiple symmetric and multiple familial lipomatosis.

Presse medicale (Paris, France : 1983), 2021

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.